Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Sep 12, 2003
VP,Finance, Strategic Planning
VP,Finance, Strategic Planning Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Sep 12, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Sep 12, 2003
Director, Ch, Pres. and Chief Exec. Off.
Director, Ch, Pres. and Chief Exec. Off. Grant, award or other acquisition pursuant to Rule 16b-3(d) 215,000 --
Sep 12, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Sep 05, 2003
Other
Other Grant, award or other acquisition pursuant to Rule 16b-3(d) 90,000 --
Sep 05, 2003
Director, Ch, Pres. and Chief Exec. Off.
Director, Ch, Pres. and Chief Exec. Off. Grant, award or other acquisition pursuant to Rule 16b-3(d) 225,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 --
Jul 31, 2003
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.